These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 7475055)

  • 1. Cardiovascular effects of the novel potassium channel opener UR-8225.
    Tamargo J; Pérez O; Delpón E; García-Rafanell J; Gómez L; Cavalcanti F
    J Cardiovasc Pharmacol; 1995 Aug; 26(2):295-305. PubMed ID: 7475055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of the novel potassium channel opener, UR-8225, on contractile responses in rat isolated smooth muscle.
    Perez-Vizcaino F; Casis O; Rodriguez R; Gomez LA; Garcia Rafanell J; Tamargo J
    Br J Pharmacol; 1993 Nov; 110(3):1165-71. PubMed ID: 8298804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of KRN4884, a novel K channel opener, on the cardiovascular system in anesthetized dogs: a comparison with levcromakalim, nilvadipine, and nifedipine.
    Izumi H; Jinno Y; Kaneta S; Tanaka Y; Okada Y; Izawa T; Ogawa N
    J Cardiovasc Pharmacol; 1995 Aug; 26(2):189-97. PubMed ID: 7475042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemodynamic profile of SKP-450, a new potassium-channel activator.
    Lee BH; Yoo SE; Shin HS
    J Cardiovasc Pharmacol; 1998 Jan; 31(1):85-94. PubMed ID: 9456282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The antihypertensive property of NIP-121, a novel potassium channel opener in rats.
    Masuda Y; Arakawa C; Yokoyama T; Shigenobu K; Tanaka S
    J Cardiovasc Pharmacol; 1991 Aug; 18(2):190-7. PubMed ID: 1717778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antihypertensive and cardiovascular effects of a new potassium channel opener, TCV-295, in rats and dogs.
    Kusumoto K; Awane Y; Kitayoshi T; Fujiwara S; Hashiguchi S; Terashita Z; Shiraishi M; Watanabe T
    J Cardiovasc Pharmacol; 1994 Dec; 24(6):929-36. PubMed ID: 7898076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preclinical pharmacology of Ro 31-6930, a new potassium channel opener.
    Paciorek PM; Burden DT; Burke YM; Cowlrick IS; Perkins RS; Taylor JC; Waterfall JF
    J Cardiovasc Pharmacol; 1990 Feb; 15(2):188-97. PubMed ID: 1689412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impaired action of levcromakalim on ATP-sensitive K+ channels in mesenteric artery cells from spontaneously hypertensive rats.
    Ohya Y; Setoguchi M; Fujii K; Nagao T; Abe I; Fujishima M
    Hypertension; 1996 Jun; 27(6):1234-9. PubMed ID: 8641729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RWJ 26629, a new potassium channel opener and vascular smooth muscle relaxant: a potential antihypertensive and antianginal agent.
    Katz LB; Giardino EC; Salata JJ; Moore JB; Falotico R
    J Pharmacol Exp Ther; 1993 Nov; 267(2):648-56. PubMed ID: 8246137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Y-27152, a long-acting K+ channel opener with less tachycardia: antihypertensive effects in hypertensive rats and dogs in conscious state.
    Nakajima T; Shinohara T; Yaoka O; Fukunari A; Shinagawa K; Aoki K; Katoh A; Yamanaka T; Setoguchi M; Tahara T
    J Pharmacol Exp Ther; 1992 May; 261(2):730-6. PubMed ID: 1578381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antihypertensive and haemodynamic properties of the potassium channel activating (-) enantiomer of cromakalim in animal models.
    Clapham JC; Hamilton TC; Longman SD; Buckingham RE; Campbell CA; Ilsley GL; Gout B
    Arzneimittelforschung; 1991 Apr; 41(4):385-91. PubMed ID: 1907150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The antihypertensive and cardioprotective effects of (-)-MJ-451, an ATP-sensitive K(+) channel opener.
    Lee YM; Yen MH; Peng YY; Sheu JR; Chen YC; Chang MJ; Cheng CY
    Eur J Pharmacol; 2000 May; 397(1):151-60. PubMed ID: 10844109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. K+ channel activators, acute glucose tolerance and glibenclamide-induced hypoglycaemia in the hypertensive rat.
    Clapham JC; Trail BK; Hamilton TC
    Eur J Pharmacol; 1994 May; 257(1-2):79-85. PubMed ID: 8082711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemodynamic and cardiac effects of BMS-180448, a novel K+ATP opener, in anesthetized dogs and isolated rat hearts.
    D'Alonzo AJ; Grover GJ; Darbenzio RB; Sewter JC; Hess TA; Dzwonczyk S; Sleph PG
    Pharmacology; 1996 Feb; 52(2):101-12. PubMed ID: 8851631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative study of vasodilator effects of the potassium channel openers NIP-121 and levcromakalim in dogs and rats.
    Yamashita T; Masuda Y; Kawamura N; Fujikura N; Tanaka S
    Jpn J Pharmacol; 1995 Jun; 68(2):145-52. PubMed ID: 7563971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the airways relaxant and hypotensive potencies of the potassium channel activators BRL 55834 and levcromakalim (BRL 38227) in vivo in guinea-pigs and rats.
    Bowring NE; Arch JR; Buckle DR; Taylor JF
    Br J Pharmacol; 1993 Aug; 109(4):1133-9. PubMed ID: 8401925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovascular effects of YM099, a novel K+ channel opener, in anesthetized and conscious dogs.
    Uchida W; Hirano Y; Taguchi T; Masuda N; Shirai Y; Satoh N; Takenaka T
    Eur J Pharmacol; 1994 Nov; 264(3):285-93. PubMed ID: 7698167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of an ATP sensitive potassium channel opener, levcromakalim, on coronary arterial microvessels in the beating canine heart.
    Sato K; Kanatsuka H; Sekiguchi N; Akai K; Wang Y; Sugimura A; Kumagai T; Komaru T; Shirato K
    Cardiovasc Res; 1994 Dec; 28(12):1780-6. PubMed ID: 7867030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. KRN4884, a novel K channel opener: antihypertensive effects in conscious renal hypertensive dogs.
    Kawahara J; Jinno Y; Endo M; Izumi H; Takeuchi A; Izawa T
    J Cardiovasc Pharmacol; 1997 Jun; 29(6):814-9. PubMed ID: 9234664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Action potential shortening and negative inotropic effects of a novel potassium channel opener, NIP-121, as compared with cromakalim in guinea pig ventricular myocardium.
    Shigenobu K; Kageyama C; Watanabe M
    Jpn J Pharmacol; 1991 Sep; 57(1):117-21. PubMed ID: 1800795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.